home · filing · 0001104659-24-109855
8-K
filed October 18, 2024, 7:59 PM ET
ticker ZURA
CIK 0001855644
leadership
confidence high
sentiment neutral
materiality 0.50
Zura Bio CSO Michael Howell departs effective Oct 15, 2024; no successor named
Zura Bio Ltd
Chief Scientific Officer Michael Howell separated from Zura Bio on October 15, 2024.
Separation not related to financial or operating results or any disagreements.
No replacement for the CSO position has been announced.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Michael Howell
Chief Scientific Officer
Effective 2024-10-15
Filed October 18, 2024, 7:59 PM ET
On and effective October 15, 2024, Michael Howell, the Chief Scientific Officer of Zura Bio Limited (the “ Company ”), was separated from the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Howell departed as Chief Scientific Officer at Zura Bio Ltd.
Action separated
Role Chief Scientific Officer
Exact text from the filing
On and effective October 15, 2024, Michael Howell, the Chief Scientific Officer of Zura Bio Limited (the “ Company ”), was separated from the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-24-109855
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.